Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386001![]() (US10287300, Compound A8 | {2-(4-Chlorophenyl)-2-[4...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 62 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386002![]() (Dimethyl-[2-[4-(5,6,7,8-tetrahydro-pyrido[2,3-d]py...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 62 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386016![]() (2-(4-Fluoro-phenyl)-2-[4-(5,6,7,8-tetrahydro-pyrid...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 62 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386002![]() (Dimethyl-[2-[4-(5,6,7,8-tetrahydro-pyrido[2,3-d]py...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 62 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM385993![]() (2-(1-(2,3-dihydro-1H-pyrrolo[2,3]pyrimidin-4-yl)pi...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 62 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386012![]() (US10287300, Compound A18 | {2-(4-Chloro-3-fluoro-p...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 62 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386011![]() (2-(4-Chloro-phenyl)-2-[4-(5,6,7,8-tetrahydro-pyrid...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 62 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386010![]() (2-[4-(5,6,7,8-Tetrahydro-pyrido[2,3-d]pyrimidin-4-...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 62 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM385992![]() (2-(1-(5,6,7,8-tetrahydro-1,8-naphthyridin-4-yl)pip...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 62 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386013![]() (US10287300, Compound A19 | {2-(3-Fluoro-4-trifluor...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 62 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386013![]() (US10287300, Compound A19 | {2-(3-Fluoro-4-trifluor...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 62 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386006![]() (2-(4-Chloro-phenyl)-2-[4-(6,7-dihydro-5H-pyrrolo[2...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 62 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386010![]() (2-[4-(5,6,7,8-Tetrahydro-pyrido[2,3-d]pyrimidin-4-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 62 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM385993![]() (2-(1-(2,3-dihydro-1H-pyrrolo[2,3]pyrimidin-4-yl)pi...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 62 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386014![]() (2-(4-fluorophenyl)-2-[4-(7,8-dihydro-6H-pyrimido[5...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 62 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386000![]() (US10287300, Compound A7 | {2-(4-Chlorophenyl)-2-[4...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386020![]() (4-{4-[2-dimethylamino-1-(4-chloro-phenyl)-ethyl]-p...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386004![]() (2-(4-Chlorophenyl)-2-[4-(7,8-dihydro-6H-pyrimido[5...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386009![]() (US10287300, Compound A15 | {2-(4-Chloro-3-fluoro-p...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386059![]() (4-(4-(1-(4-chloro-3-fluorophenyl)-2-(pyrrolidin-1-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386001![]() (US10287300, Compound A8 | {2-(4-Chlorophenyl)-2-[4...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386014![]() (2-(4-fluorophenyl)-2-[4-(7,8-dihydro-6H-pyrimido[5...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386016![]() (2-(4-Fluoro-phenyl)-2-[4-(5,6,7,8-tetrahydro-pyrid...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386012![]() (US10287300, Compound A18 | {2-(4-Chloro-3-fluoro-p...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386009![]() (US10287300, Compound A15 | {2-(4-Chloro-3-fluoro-p...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386000![]() (US10287300, Compound A7 | {2-(4-Chlorophenyl)-2-[4...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM385999![]() (US10287300, Compound A6 | [2-[4-(6,7-Dihydro-5H-py...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386006![]() (2-(4-Chloro-phenyl)-2-[4-(6,7-dihydro-5H-pyrrolo[2...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM385992![]() (2-(1-(5,6,7,8-tetrahydro-1,8-naphthyridin-4-yl)pip...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386011![]() (2-(4-Chloro-phenyl)-2-[4-(5,6,7,8-tetrahydro-pyrid...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386005![]() (US10287300, Compound A12 | [2-[4-(7,8-Dihydro-6H-p...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM385998![]() (US10287300, Compound A5 | [2-[4-(7,8-Dihydro-6H-py...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM385999![]() (US10287300, Compound A6 | [2-[4-(6,7-Dihydro-5H-py...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386056![]() (4-(4-(1-(4-chloro-3-fluorophenyl)-2-(dimethylamino...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386022![]() (4-{4-[2-dimethylamino-1-(4-trifluoromethyl-phenyl)...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM385996![]() (US10287300, Compound A4 | {2-(4-Chlorophenyl)-2-[4...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386003![]() (2-[4-(7,8-Dihydro-6H-pyrimido[5,4-b][1,4]oxazin-4-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386015![]() (US10287300, Compound A21 | [2-[4-(6,7-Dihydro-5H-p...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 750 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386024![]() (4-{4-[1-(4-chloro-phenyl)-2-(pyrrolidin-yl)-ethyl]...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 750 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386027![]() (4-{4-[1-(4-chloro-phenyl)-2-(piperidin-yl)-ethyl]-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 750 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386028![]() (4-{4-[1-(4-trifluoro-phenyl)-2-(piperidin-yl)-ethy...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 750 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386022![]() (4-{4-[2-dimethylamino-1-(4-trifluoromethyl-phenyl)...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 750 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386008![]() (2-[4-(6,7-Dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 750 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386005![]() (US10287300, Compound A12 | [2-[4-(7,8-Dihydro-6H-p...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 750 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386024![]() (4-{4-[1-(4-chloro-phenyl)-2-(pyrrolidin-yl)-ethyl]...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 750 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386060![]() (4-(4-(1-(4-chloro-3-fluorophenyl)-2-(piperidin-1-y...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 750 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386004![]() (2-(4-Chlorophenyl)-2-[4-(7,8-dihydro-6H-pyrimido[5...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 750 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386020![]() (4-{4-[2-dimethylamino-1-(4-chloro-phenyl)-ethyl]-p...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 750 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386003![]() (2-[4-(7,8-Dihydro-6H-pyrimido[5,4-b][1,4]oxazin-4-...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 750 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386008![]() (2-[4-(6,7-Dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 750 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386041![]() (4-(4-(2-(dimethylamino)-1-(o-tolyl)ethyl)piperazin...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386044![]() (4-(4-(2-amino)-1-(3,4-difluorophenyl)ethyl)piperaz...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386049![]() (4-(4-(1-(3,4-difluorophenyl)-2-(pyrrolidin-1-yl)et...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386052![]() (4-(4-(2-(azetidin-1-yl)-1-(3-chloro-4-fluorophenyl...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386053![]() (4-(4-(1-(3-chloro-4-fluorophenyl)-2-(pyrrolidin-1-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386056![]() (4-(4-(1-(4-chloro-3-fluorophenyl)-2-(dimethylamino...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386057![]() (4-(4-(1-(4-chloro-3-fluorophenyl)-2-(methylamino)e...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386060![]() (4-(4-(1-(4-chloro-3-fluorophenyl)-2-(piperidin-1-y...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386015![]() (US10287300, Compound A21 | [2-[4-(6,7-Dihydro-5H-p...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386033![]() (4-(4-(1-(2-fluorophenyl)-2-(piperidin-1-yl)ethyl)p...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386033![]() (4-(4-(1-(2-fluorophenyl)-2-(piperidin-1-yl)ethyl)p...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386034![]() (4-(4-(2-amino-1-(2-chlorophenyl)ethyl)piperazin-1-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386042![]() (4-(4-(2-(pyrrolidin-1-yl)-1-(o-tolyl)ethyl)piperaz...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386048![]() (4-(4-(2-(azetidin-1-yl)-1-(3,4-difluorophenyl)ethy...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386052![]() (4-(4-(2-(azetidin-1-yl)-1-(3-chloro-4-fluorophenyl...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386061![]() (4-(4-(2((2-(dimethylamino)ethyl)amino)-1-(4-(trifl...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386018![]() (4-{4-[2-dimethylamino-1-(4-fluoro-phenyl)-ethyl]-p...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386021![]() (4-{4-[2-dimethylamino-1-(3-chloro-phenyl)-ethyl]-p...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386031![]() (4-(4-(2-(dimethylamino)-1-(2-fluorophenyl)ethyl)pi...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386041![]() (4-(4-(2-(dimethylamino)-1-(o-tolyl)ethyl)piperazin...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386042![]() (4-(4-(2-(pyrrolidin-1-yl)-1-(o-tolyl)ethyl)piperaz...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386045![]() (4-(4-(1-(3,4-difluorophenyl)-2-(dimethylamino)ethy...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386049![]() (4-(4-(1-(3,4-difluorophenyl)-2-(pyrrolidin-1-yl)et...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386050![]() (4-(4-(1-(3,4-difluorophenyl)-2-(piperidin-1-yl)eth...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386051![]() (4-(4-(1-(3-chloro-4-fluorophenyl)-2-(dimethylamino...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386058![]() (4-(4-(2-(azetidin-1-yl)-1-(4-chloro-3-fluorophenyl...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386059![]() (4-(4-(1-(4-chloro-3-fluorophenyl)-2-(pyrrolidin-1-...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386062![]() (4-(4-(2-((2-(dimethylamino)ethyl)amino)-1-(3-(trif...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386025![]() (4-{4-[1-(4-fluoro-phenyl)-2-(piperidin-yl)-ethyl]-...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386025![]() (4-{4-[1-(4-fluoro-phenyl)-2-(piperidin-yl)-ethyl]-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386029![]() (4-{4-[2-Pyrrolidin-1-yl-1-(4-trifluoromethyl-pheny...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386030![]() (4-(4-(1-(2-fluorophenyl)-2-(pyrrolidin-1-yl)ethyl)...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386040![]() (4-(4-(1-(2-chlorophenyl)-2-(piperidin-1-yl)ethyl)p...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386043![]() (4-(4-(2-(piperidin-1-yl)-1-(o-tolyl)ethyl)piperazi...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386047![]() (4-(4-(1-(3,4-difluorophenyl)-2-(methylamino)ethyl)...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386053![]() (4-(4-(1-(3-chloro-4-fluorophenyl)-2-(pyrrolidin-1-...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386063![]() (4-(4-(2-((2-(dimethylamino)ethyl)amino)-1-(p-tolyl...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM385994![]() (2-(1-(6,7-dihydro-5H-cyclopenta[b]pyrimidin-4-yl)p...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386017![]() (2-[1-(7,8-Dihydro-6H-pyrimido[5,4-b][1,4]oxazin-4-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386027![]() (4-{4-[1-(4-chloro-phenyl)-2-(piperidin-yl)-ethyl]-...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386031![]() (4-(4-(2-(dimethylamino)-1-(2-fluorophenyl)ethyl)pi...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386034![]() (4-(4-(2-amino-1-(2-chlorophenyl)ethyl)piperazin-1-...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386036![]() (4-(4-(1-(2-chlorophenyl)-2-(methylamino)ethyl)pipe...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386053![]() (4-(4-(1-(3-chloro-4-fluorophenyl)-2-(pyrrolidin-1-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386063![]() (4-(4-(2-((2-(dimethylamino)ethyl)amino)-1-(p-tolyl...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386019![]() (4-{4-[2-dimethylamino-1-(3-fluoro-phenyl)-ethyl]-p...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386028![]() (4-{4-[1-(4-trifluoro-phenyl)-2-(piperidin-yl)-ethy...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386032![]() (4-(4-(2-(azetidin-1-yl)-1-(2-fluorophenyl)ethyl)pi...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386037![]() (4-(4-(2-(azetidin-1-yl)-1-(2-chlorophenyl)ethyl)pi...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386037![]() (4-(4-(2-(azetidin-1-yl)-1-(2-chlorophenyl)ethyl)pi...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386044![]() (4-(4-(2-amino)-1-(3,4-difluorophenyl)ethyl)piperaz...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386047![]() (4-(4-(1-(3,4-difluorophenyl)-2-(methylamino)ethyl)...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386051![]() (4-(4-(1-(3-chloro-4-fluorophenyl)-2-(dimethylamino...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386053![]() (4-(4-(1-(3-chloro-4-fluorophenyl)-2-(pyrrolidin-1-...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM385994![]() (2-(1-(6,7-dihydro-5H-cyclopenta[b]pyrimidin-4-yl)p...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386029![]() (4-{4-[2-Pyrrolidin-1-yl-1-(4-trifluoromethyl-pheny...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386032![]() (4-(4-(2-(azetidin-1-yl)-1-(2-fluorophenyl)ethyl)pi...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386035![]() (4-(4-(1-(2-chlorophenyl)-2-(dimethylamino)ethyl)pi...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386035![]() (4-(4-(1-(2-chlorophenyl)-2-(dimethylamino)ethyl)pi...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386039![]() (4-(4-(1-(2-chlorophenyl)-2-(pyrrolidin-1-yl)ethyl)...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386045![]() (4-(4-(1-(3,4-difluorophenyl)-2-(dimethylamino)ethy...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386048![]() (4-(4-(2-(azetidin-1-yl)-1-(3,4-difluorophenyl)ethy...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386050![]() (4-(4-(1-(3,4-difluorophenyl)-2-(piperidin-1-yl)eth...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386057![]() (4-(4-(1-(4-chloro-3-fluorophenyl)-2-(methylamino)e...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386061![]() (4-(4-(2((2-(dimethylamino)ethyl)amino)-1-(4-(trifl...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386019![]() (4-{4-[2-dimethylamino-1-(3-fluoro-phenyl)-ethyl]-p...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386023![]() (4-{4-[1-(4-fluoro-phenyl)-2-(pyrrolidin-yl)-ethyl]...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386023![]() (4-{4-[1-(4-fluoro-phenyl)-2-(pyrrolidin-yl)-ethyl]...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386043![]() (4-(4-(2-(piperidin-1-yl)-1-(o-tolyl)ethyl)piperazi...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386058![]() (4-(4-(2-(azetidin-1-yl)-1-(4-chloro-3-fluorophenyl...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386062![]() (4-(4-(2-((2-(dimethylamino)ethyl)amino)-1-(3-(trif...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM385996![]() (US10287300, Compound A4 | {2-(4-Chlorophenyl)-2-[4...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM385998![]() (US10287300, Compound A5 | [2-[4-(7,8-Dihydro-6H-py...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386017![]() (2-[1-(7,8-Dihydro-6H-pyrimido[5,4-b][1,4]oxazin-4-...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386018![]() (4-{4-[2-dimethylamino-1-(4-fluoro-phenyl)-ethyl]-p...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386021![]() (4-{4-[2-dimethylamino-1-(3-chloro-phenyl)-ethyl]-p...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386030![]() (4-(4-(1-(2-fluorophenyl)-2-(pyrrolidin-1-yl)ethyl)...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386036![]() (4-(4-(1-(2-chlorophenyl)-2-(methylamino)ethyl)pipe...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proline-rich AKT1 substrate 1 (Homo sapiens (Human)) | BDBM386039![]() (4-(4-(1-(2-chlorophenyl)-2-(pyrrolidin-1-yl)ethyl)...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description A TTP Mosquito liquid handling instrument was used to place 125 nl of the appropriate concentration of inhibitor in 100% DMSO (for a dose response cu... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P70S6K (T412E) (Homo sapiens (Human)) | BDBM386040![]() (4-(4-(1-(2-chlorophenyl)-2-(piperidin-1-yl)ethyl)p...) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Patent GmbH US Patent | Assay Description P70S6K inhibitor compounds were diluted and plated in 96 well plates. A reaction mixture including the following components was then added to the com... | US Patent US10287300 (2019) BindingDB Entry DOI: 10.7270/Q26M394B | |||||||||||
More data for this Ligand-Target Pair |